[Inhibition of prolactin by an ergot-alkaloid derivative].
D004341:Drug Evaluation; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007775:Lactation Disorders / Q000188:drug therapy; D011247:Pregnancy; D011388:Prolactin / Q000037:antagonists & inhibitors*
D004876:Ergot Alkaloids; D011388:Prolactin
Prolaktinhemmung mittels eines Ergotalkaloidderivates.